SCOPUS 정보 검색 플랫폼

American Journal of Neuroradiology

Volumn 32, Issue 6, 2011, Pages 1002-1003

Panitumumab (Vectibix)

(2) Gemmete, Joseph J a Mukherji, S K a

a UNIVERSITY OF MICHIGAN HEALTH SYSTEM (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; KRISTEN RAT SARCOMA VIRAL ONCOGENE HOMOLOG; PANITUMUMAB; TUMOR MARKER; UNCLASSIFIED DRUG;

ABDOMINAL PAIN; ACNE; ARTICLE; BODY WEIGHT; COLORECTAL CANCER; CONSTIPATION; DIARRHEA; DRUG COST; DRUG ELIMINATION; DRUG ERUPTION; DRUG HALF LIFE; DRUG INDICATION; DRUG MECHANISM; DRUG PROTEIN BINDING; ERYTHEMA; EYE TOXICITY; FATIGUE; HUMAN; HYPOMAGNESEMIA; LUNG EMBOLISM; LUNG FIBROSIS; MESTATIC COLORECTAL CANCER; METASTASIS; NAUSEA; PARONYCHIA; PRURITUS; SKIN EXFOLIATION; SKIN FISSURE; TREATMENT DURATION; WILD TYPE;

ANTIBODIES, MONOCLONAL; ANTINEOPLASTIC AGENTS; COLORECTAL NEOPLASMS; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS;

EID: 79959289494 PISSN: 01956108 EISSN: 1936959X Source Type: Journal
DOI: 10.3174/ajnr.A2601 Document Type: Article

Times cited : (20)

References (10)

1
- 0037302445
- Epidermal growth factor receptor as a therapeutic target in colorectal cancer
- Cohen RB. Epidermal growth factor receptor as a therapeutic target in colorectal cancer. Clin Colorectal Cancer 2003;2:246-51 (Pubitemid 36367313)
- (2003) Clinical Colorectal Cancer , vol.2 , Issue.4 , pp. 246-251
- Cohen, R.B.¹

2
- 77956371812
- Targeting colorectal cancer with human anti-EGFR monoclonocal antibodies: Focus on panitumumab
- Kim GP, Grothey A. Targeting colorectal cancer with human anti-EGFR monoclonocal antibodies: focus on panitumumab. Biologics 2008;2:223-28
- (2008) Biologics , vol.2 , pp. 223-228
- Kim, G.P.¹ Grothey, A.²

3
- 77954598377
- Spotlight on panitumumab in metastatic colorectal cancer
- Keating GM. Spotlight on panitumumab in metastatic colorectal cancer. BioDrugs 2010;1 24:275-78
- (2010) BioDrugs , vol.124 , pp. 275-278
- Keating, G.M.¹

4
- 77952602038
- Panitumumab: A review of its use in metastatic colorectal cancer
- Keating GM. Panitumumab: a review of its use in metastatic colorectal cancer. Drugs 28 2010;70:1059-78
- (2010) Drugs , vol.28 , Issue.70 , pp. 1059-1078
- Keating, G.M.¹

5
- 61549138171
- Targeting colorectal cancer with anti-epidermal growth factor receptor antibodies: Focus on panitumumab
- Hoda D, Simon GR, Garrett CR. Targeting colorectal cancer with anti-epidermal growth factor receptor antibodies: focus on panitumumab. Ther Clin Risk Manag 2008;4:1221-27
- (2008) Ther Clin Risk Manag , vol.4 , pp. 1221-1227
- Hoda, D.¹ Simon, G.R.² Garrett, C.R.³

6
- 69949127786
- Anti-epidermal growth factor receptor monoclonal antibodies in cancer therapy
- Martinelli E, De Palma R, Orditura M, et al. Anti-epidermal growth factor receptor monoclonal antibodies in cancer therapy. Clin Exp Immunol 2009;158:1-9
- (2009) Clin Exp Immunol , vol.158 , pp. 1-9
- Martinelli, E.¹ De Palma, R.² Orditura, M.³

7
- 70449112777
- Panitumumab
- Dubois EA, Cohen AF. Panitumumab. Br J Clin Pharmacol 2009;68:482-83
- (2009) Br J Clin Pharmacol , vol.68 , pp. 482-483
- Dubois, E.A.¹ Cohen, A.F.²

8
- 79959298055
- Panitumumab: The evidence for its use in the treatment of metastatic colorectal cancer
- Berardi R, Onofri A, Pistelli M, et al. Panitumumab: the evidence for its use in the treatment of metastatic colorectal cancer. Core Evid 2010;5:61-76
- (2010) Core Evid , vol.5 , pp. 61-76
- Berardi, R.¹ Onofri, A.² Pistelli, M.³

9
- 77955890462
- package insert. Thousand Oaks, California: Amgen Inc
- Vectibix (panitumumab) [package insert]. Thousand Oaks, California: Amgen Inc; 2006
- (2006) Vectibix (Panitumumab)

10
- 38849152398
- Targeted therapies: A new generation of cancer treatments
- Gerber DE. Targeted therapies: a new generation of cancer treatments. Am Fam Physician 2008;77:311-19 (Pubitemid 351206593)
- (2008) American Family Physician , vol.77 , Issue.3 , pp. 311-319
- Gerber, D.E.¹

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.